| Dr Helen Ngo, PHARMD | |
|
12275 Perris Blvd, Moreno Valley, CA 92557-7432 | |
| (951) 242-8717 | |
| (951) 242-8787 |
| Full Name | Dr Helen Ngo |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 12275 Perris Blvd, Moreno Valley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831525583 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH69674 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Helen Ngo, PHARMD 118 E Base Line Rd, Rialto, CA 92376-3607 Ph: (909) 562-0267 | Dr Helen Ngo, PHARMD 12275 Perris Blvd, Moreno Valley, CA 92557-7432 Ph: (951) 242-8717 |
News Archive
Children under five living in sub-Saharan Africa are at greater risk than older children of developing a long-term parasitic disease, research suggests.
Researchers at the Institute of Biochemistry and Molecular Biology I of the Heinrich-Heine University, D-sseldorf, Germany, investigated the relationship between fruit and vegetable intake, plasma antioxidant micronutrient status and cognitive performance in healthy subjects aged 45 to 102 years.
On rare occasion, the light-sensing photoreceptor cells in the eye misfire and signal to the brain as if they have captured photons, when in reality they haven't. For years this phenomenon remained a mystery. Reporting in the June 10 issue of Science, neuroscientists at the Johns Hopkins University School of Medicine have discovered that a light-capturing pigment molecule in photoreceptors can be triggered by heat, as well, giving rise to these false alarms.
Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.
› Verified 3 days ago
Osama Bishay, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24991 Alessandro Blvd, Moreno Valley, CA 92553 Phone: 951-485-4450 | |
Dr. Thu Kieu Nguyen Huynh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4613 | |
Hong My Lam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12275 Perris Blvd, Moreno Valley, CA 92557 Phone: 951-242-8717 | |
Grace Shinn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 | |
Dr. Chi Wah Simon Chou, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25011 Alessandro Blvd, Moreno Valley, CA 92553 Phone: 951-485-1116 | |
Oksana Niknafs, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4515 | |
Dr. Linda Tang Ortega, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23965 Ironwood Ave, Moreno Valley, CA 92557 Phone: 951-242-1742 Fax: 951-242-7291 |